46-60 of 134
Statins and Safety: What the Data Say About Dementia, Cancer, and More
MinuteCE®Statins and Safety: What the Data Say About Dementia, Cancer, and More
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
MinuteCE®Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
Target in Sight: Escalating Therapy to Reach LDL-C Goals
MinuteCE®Target in Sight: Escalating Therapy to Reach LDL-C Goals
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
MinuteCE®Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
MinuteCE®Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
- advertisement
Bridging ASCVD Care Between Academic and Rural Settings
MinuteCE®Bridging ASCVD Care Between Academic and Rural Settings
Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
CME/CENonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CECracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
MinuteCE®An Overview of Current and Emerging Treatment Options for Hemophilia A & B
The Impact of Hemophilia Across Patients’ Lives
MinuteCE®The Impact of Hemophilia Across Patients’ Lives
- advertisement
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
MinuteCE®Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
Evaluating Emerging Treatment Options: Rebalancing Therapies
MinuteCE®Evaluating Emerging Treatment Options: Rebalancing Therapies













































